SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

LUNRs sharp rally is being tied by traders to anticipated NASA CLPS 2.0 awards and related lunar-program updates, with some claiming the company is a selected vendor while others question whether an award announcement is confirmed. Bulls are celebrating the move and speculating about short covering, while skeptics warn it could fade; the upcoming earnings report is also in focus.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowheads clinical pipeline is drawing attention, particularly strong Phase 3 plozasiran results in severe hypertriglyceridemia and early ARO-MAPT evidence of tau reduction after subcutaneous dosing. Bulls see validation of the broader RNAi platform, while others focus on the stocks muted or weakening reaction and note that MAPTs biomarker results do not yet establish clinical benefit.

Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE.

Berkshire Hathaway Inc. - Ordinary Shares - Class B

Berkshires Q3 results are drawing attention as weaker operating performance, particularly in insurance underwriting, contrasts with a sharp increase in share repurchases. Traders are split between concern over the earnings softness and reduced stock buying, and support for the buybacks and Berkshires cash-rich balance sheet.

American Express Co. engages in the provision of card-issuing, merchant-acquiring, and card network businesses. Its products and services include credit cards, business credit cards, corporate programs, gift cards, savings accounts and CDs, and the American Express App. It operates through the following segments: the United States Consumer Services (USCS), Commercial Services (CS), International Card Services (ICS), Global Merchant and Network Services (GMNS), and Corporate and Other. The USCS segment includes proprietary consumer cards and provides services to United States consumers. The CS segment offers corporate and small business cards and provides services to United States businesses. The ICS segment provides consumers, small businesses, and corporate cards outside the United States. The GMNS segment is involved in operating a global payments network that processes and settles card transactions, acquires merchants, and provides multi-channel marketing programs and capabilities, services and data analytics. The Corporate and Other segment covers corporate functions and certain other businesses and operations. It also operates through the following geographical segments: United States, EMEA, APAC, LACC, and Other. The EMEA segment represents Europe, the Middle East, and Africa. The APAC segment refers to Asia Pacific, Australia, and New Zealand. The LACC segment focuses on Latin America, Canada, and the Caribbean. The Other segment includes net costs which are not directly allocated to specific geographic regions. The company was founded by Henry Wells, William G. Fargo, and John Warren Butterfield on March 28, 1850 and is headquartered in New York, NY.

American Express Co.

American Express is drawing attention over reported stock sales by CEO Stephen Squeri and another senior executive, with traders debating whether the insider selling signals concern or is routine. Speculation about dark-pool activity is also circulating, while other traders remain bullish on AXPs valuation and long-term prospects.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

FDA accelerated approval of Replimunes melanoma therapy Tudriqev has driven a sharp rebound and talk of a short squeeze, with bulls focused on the commercial launch and institutional demand. Bears counter that adoption, efficacy and future dilution remain risks.

Eaton Corp. Plc is a power management company, which provides energy-efficient solutions for electrical, hydraulic, and mechanical power. It operates through the following segments: Electrical Americas and Electrical Global; Aerospace, Vehicle, and eMobility. The Electrical Americas and Electrical Global segments engage in sales contracts for electrical components, industrial components, power distribution and assemblies, residential products, single and three phase power quality, wiring devices, circuit protection, utility power distribution, power reliability equipment, and service. The Aerospace segment supplies aerospace fuel, hydraulics, and pneumatic systems for commercial and military use. The Vehicle segment deals with the design, manufacture, marketing, and supply of drivetrain and powertrain systems and critical components that reduce emissions and improve fuel economy, stability, performance and safety of cars, light trucks and commercial vehicles. The eMobility segment designs, manufactures, markets, and supplies electrical and electronic components and systems that improve the power management and performance of both on-road and off-road vehicles. The company was founded in 1911 and is headquartered in Dublin, Ireland.

Eaton Corporation plc

Eatons strong third-quarter results and higher full-year guidance, alongside accelerating electrical orders and backlog tied to data-center power demand, are driving attention. Many traders view the report as confirmation of the AI infrastructure opportunity, while others question whether backlogs are secure if projects face delays and whether the stocks valuation already reflects much of that growth.

Kura Oncology, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of medicines for the treatment of cancer. Its pipeline includes Tipifarnib, which is a Farnesyl transferase inhibitor for HRAS Mutant Solid Tumors, Chronic Myelomonocytic Leukemia, KO-947, which is an ERK inhibitor for MAPK Pathway Tumors, and KO-539, which is a Menin MLL inhibitor for acute leukemias. The company was founded by Troy E. Wilson, Yi Liu, Pingda Ren and Antonio Gualberto on August 22, 2014 and is headquartered in San Diego, CA.

Kura Oncology Inc

Concern that Johnson & Johnsons bleximenib could challenge Kuras ziftomenib in frontline AML is driving debate, with traders questioning whether differences in prior venetoclax exposure make the competitor data less comparable. Some view the selloff as an overreaction and point to KOMZIFTIs commercial progress and upcoming company updates, while others see a genuine competitive threat.

Stellar (XLM) is a cryptocurrency launched in 2014. Stellar has a current supply of 50,001,786,837.39707 with 35,366,684,616.305855 in circulation. The last known price of Stellar is 0.15346137 USD and is down -1.11 over the last 24 hours. It is currently trading on 848 active market(s) with $109,670,947.94 traded over the last 24 hours. More information can be found at https://www.stellar.org.

Stellar Lumens

XLM is drawing attention amid a persistent selloff and frustration that tokenization and institutional-adoption developments, including the discussed DTCC plans, have not translated into lasting price strength. Bears blame ongoing selling and weak token economics, while bulls continue to buy dips and cite Stellars real-world-asset and payments activity as a longer-term case.

Zebec Network (ZBCN) is a cryptocurrency launched in 2022and operates on the Solana platform. Zebec Network has a current supply of 99,998,768,505.961324. The last known price of Zebec Network is 0.00185282 USD and is down -2.31 over the last 24 hours. It is currently trading on 133 active market(s) with $11,016,611.66 traded over the last 24 hours. More information can be found at https://zebec.io/.

Zebec Network

Zebecs payroll and payments expansionincluding community discussion of MoneyGram/Stellar, Germany, and Robinhood Chain developmentsis driving attention as holders look for real-world adoption to translate into ZBCN demand. Bullish traders are accumulating on the partnership and buyback thesis, while skeptics point to weak price action and question whether business growth is creating meaningful token value; rumored Ripple or BlackRock links remain speculation.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevrons stronger-than-expected quarterly results, with refining strength amid tight diesel markets, are driving attention. Traders are weighing the earnings and cash-generation story against questions about whether elevated refining margins and oil-market support will last.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Canopy Growth Corporation: 3 Key Takeaways for Long-Term Investors

Key PointsInternational cannabis net revenue grew 141% year over year to $12.3 million...

Canopy Growth (CGC) Q2 2027 Earnings Call Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Why Is Canopy Growth Stock Falling Friday?

Canopy Growth stock tumbles 9% after earnings and revenue miss estimates, despite strong cannabis sales and improving EBITDA.read more...

Canopy Gwth Q2 2027 Earnings Call Transcript

Canopy Gwth (TSX:WEED) reported second-quarter financial results on Friday. The transcript from the company's second-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. Forread more...

Canopy Growth Corporation (CGC) Reports Q2 Loss, Lags Revenue Estimates

Canopy Growth (CGC) delivered earnings and revenue surprises of -250.00% and -1.63%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Canopy Growth Reports Second Quarter Fiscal Year 2027 Financial Results; Net Revenue Growth of 22% Led by a 141% Increase in International Markets Cannabis

Canopy Growth Corporation (Canopy Growth, our, we or the Company) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced its financial results for the three months ended September 30, 2026 ("Q2 FY2027"). All financial information in this...

Concentra Group (CON) Tops Q3 Earnings and Revenue Estimates

Concentra (CON) delivered earnings and revenue surprises of +15.56% and +3.66%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?

Canopy Growth vs. Tilray Brands: Quarterly Revenue Scale and Consistency in Cannabis

Key PointsTilray Brands currently generates a higher total revenue base than Canopy Growth, maintaining a consistently larger top-line financial footprint across its various reported operating segments and international geographic regions during this specific tracking period...

Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know  

Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know

Canopy Growth Corporation (CGC) closed the most recent trading day at $0.68, moving +2.42% from the previous trading session.

$CGC Q2 &#39;27 Earnings Results &amp; Recap

Canopy Growth said its disciplined approach continues to show improvements in adjusted EBITDA compared to Q2 FY2026, placing it within reach of reporting positive adjusted EBITDA during fiscal 2027.

Stocktwits

Canopy Growth Corp

 Q2 '27 Earnings Results & Recap

Canopy Growth said its disciplined approach continues to show improvements in adjusted EBITDA compared to Q2 FY2026, placing it within reach of reporting positive adjusted EBITDA during fiscal 2027.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. It operates through the following segments: Cannabis, Storz and Bickel. The Cannabis segment includes the global production, distribution and sale of a diverse range of cannabis and cannabis-related products. The Storz and Bickel segment produces and sells vaporizers. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth Corporation

TLRY Stock Back Into The Limelight – A Look At The Key Developments That Sparked Investor Optimism

Equity

Bullish Sentiment

<ul class="summary-bullets"><li>The DEA rescheduling hearing that could reclassify marijuana is expected to be held on June 29.</li><li>On Thursday, the Trump Administration pushed Congress to keep hemp CBD products legal by amending the broad ban that would take effect in June.</li><li>Rival cannabis stocks jumped on the bandwagon and climbed on the optimism.</li></ul>Shares of cannabis company Tilray Brands (TLRY) attracted significant investor buzz on Friday amid optimism over an upcoming regulatory hearing that could legalize marijuana in the United States and a recent Trump administration effort to push Congress to ease hemp regulations to benefit farmers.At the time of writing, TLRY stock was up nearly 4% premarket and the top-trending ticker on Stocktwits. Shares of peers such as Canopy Growth (CGC), Aurora Cannabis (ACB), and Cronos (CRON) also traded higher. At the same time, the popular marijuana stocks tracker, the AdvisorShares Pure US Cannabis ETF (MSOS), rose more than 8%.<h1 class="st-heading-1">Office Of Management And Budget Statement</h1>According to a statement from the Office of Management and Budget on <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.whitehouse.gov/wp-content/uploads/2026/06/H.R.-8646-SAP_Updated.pdf">Thursday</a>, the Trump Administration is urging Congress to redefine final hemp-derived cannabinoid products to allow citizens to benefit from the full-spectrum CBD products before the ban takes effect in November. The update on CBD was mentioned in a statement at a recent meeting discussing the annual agriculture spending bill.Also adding to the excitement is the Drug Enforcement Administration's broader rescheduling proceeding regarding marijuana expected later this month. The hearing will decide whether the currently classified illegal drug should be moved from Schedule I to Schedule III narcotics for all commercial and medical uses at the federal level.It is notable that Tilray recently pivoted into the alcohol industry to capitalize on the growing live events and music festival market.<h1 class="st-heading-1">What Do Retail Traders Think About TLRY?</h1>On Stocktwits, retail sentiment about the TLRY stock turned ‘bullish’ from ‘bearish’ amid ‘high’ message volume over the last 24 hours.One user on the platform believes the DEA rescheduling hearings could change the entire sentiment curve overnight.<stembedurl>https://stocktwits.com/Claravery/message/655532578</stembedurl>Another pointed out that “MSOS breaking out and acting as early indicator for the June rally into the next US rescheduling step is promising.”<stembedurl>https://stocktwits.com/Beto_365/message/655521174</stembedurl><a href="https://stocktwits.com/symbol/TLRY">TLRY stock</a> has fallen more than 45%, while <a href="https://stocktwits.com/symbol/MSOS">MSOS </a>has gained over 8% so far this year, underperforming the S&amp;P 500.For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a Tilray Brands logo is seen displayed on a smartphone and in the background. (Source: Getty Images)

Shares of cannabis company Tilray Brands (TLRY) attracted significant investor buzz on Friday amid optimism over an upcoming regulatory hearing that could legalize marijuana in the United States and a recent Trump administration effort to push Congress to

Tilray stock was in focus after a recent government effort to reclassify Hemp and the upcoming DEA hearing about marijuana.

Aurora Cannabis Inc

Cronos Group Inc

AdvisorShares Pure US Cannabis ETF

Tilray Brands Inc

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$0.6515
Prev Close	$0.6757
Open	$0.6835
Dividend Yield	0.00%
50-Day Moving Average	$0.8358
Beta	1.60
Avg. Volume	2.46M
PE Ratio	-1.44

52-Week High	$2.38
52-Week Low	$0.5809
Market Capitalization	$273.35M
EPS (Annual)	-$0.6382
Price to Book	0.57
Revenue Per Employee	$182,554.32

Feed

News

Sentiment

Earnings

Fundamentals

Info

CGC Fundamentals